TOX Is Required for Development of the CD4 T Cell Lineage Gene Program

被引:52
作者
Aliahmad, Parinaz [1 ]
Kadavallore, Asha [1 ]
de la Torre, Brian [1 ]
Kappes, Dietmar [2 ]
Kaye, Jonathan [1 ]
机构
[1] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Biomed Sci, Div Immunol Res, Los Angeles, CA 90048 USA
[2] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
基金
美国国家卫生研究院;
关键词
LYMPHOCYTE DEVELOPMENT; TRANSCRIPTION FACTORS; THYMOCYTE DIFFERENTIATION; INTERLEUKIN-7; RECEPTOR; POSITIVE SELECTION; RUNX PROTEINS; REGULATES CD4; TCR SIGNALS; EXPRESSION; THPOK;
D O I
10.4049/jimmunol.1101474
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
The factors that regulate thymic development of the CD4(+) T cell gene program remain poorly defined. The transcriptional regulator ThPOK is a dominant factor in CD4(+) T cell development, which functions primarily to repress the CD8 lineage fate. Previously, we showed that nuclear protein TOX is also required for murine CD4(+) T cell development. In this study, we sought to investigate whether the requirement for TOX was solely due to a role in ThPOK induction. In apparent support of this proposition, ThPOK upregulation and CD8 lineage repression were compromised in the absence of TOX, and enforced ThPOK expression could restore some CD4 development. However, these "rescued" CD4 cells were defective in many aspects of the CD4(+) T cell gene program, including expression of Id2, Foxol, and endogenous Thpok, among others. Thus, TOX is necessary to establish the CD4(+) T cell lineage gene program, independent of its influence on ThPOK expression. The Journal of Immunology, 2011, 187: 5931-5940.
引用
收藏
页码:5931 / 5940
页数:10
相关论文
共 59 条
[1]
Hierarchical interactions control CD4 gene expression during thymocyte development [J].
Adlam, M ;
Siu, G .
IMMUNITY, 2003, 18 (02) :173-184
[2]
Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice [J].
Akashi, K ;
Kondo, M ;
vonFreedenJeffry, U ;
Murray, R ;
Weissman, IL .
CELL, 1997, 89 (07) :1033-1041
[3]
TOX provides a link between calcineurin activation and CD8 lineage commitment [J].
Aliahmad, P ;
O'Flaherty, E ;
Han, P ;
Goularte, OD ;
Wilkinson, B ;
Satake, M ;
Molkentin, JD ;
Kaye, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (08) :1089-1099
[4]
Development of all CD4 T lineages requires nuclear factor TOX [J].
Aliahmad, Parinaz ;
Kaye, Jonathan .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (01) :245-256
[5]
Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages [J].
Aliahmad, Parinaz ;
de la Torre, Brian ;
Kaye, Jonathan .
NATURE IMMUNOLOGY, 2010, 11 (10) :945-U98
[6]
CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity [J].
Azzam, HS ;
Grinberg, A ;
Lui, K ;
Shen, H ;
Shores, EW ;
Love, PE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12) :2301-2311
[7]
Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade [J].
Bain, G ;
Cravatt, CB ;
Loomans, C ;
Alberola-Ila, J ;
Hedrick, SM ;
Murre, C .
NATURE IMMUNOLOGY, 2001, 2 (02) :165-171
[8]
Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity [J].
Boos, Markus D. ;
Yokota, Yoshifumi ;
Eberl, Gerard ;
Kee, Barbara L. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (05) :1119-1130
[9]
Epigenetic propagation of CD4 expression is established by the Cd4 proximal enhancer in helper T cells [J].
Chong, Mark M. W. ;
Simpson, Natalie ;
Ciofani, Maria ;
Chen, Grace ;
Collins, Amelie ;
Littman, Dan R. .
GENES & DEVELOPMENT, 2010, 24 (07) :659-669
[10]
RUNX Transcription Factor-Mediated Association of Cd4 and Cd8 Enables Coordinate Gene Regulation [J].
Collins, Amelie ;
Hewitt, Susannah L. ;
Chaumeil, Julie ;
Sellars, MacLean ;
Micsinai, Mariann ;
Allinne, Jeanne ;
Parisi, Fabio ;
Nora, Elphege P. ;
Bolland, Dan J. ;
Corcoran, Anne E. ;
Kluger, Yuval ;
Bosselut, Remy ;
Ellmeier, Wilfried ;
Chong, Mark M. W. ;
Littman, Dan R. ;
Skok, Jane A. .
IMMUNITY, 2011, 34 (03) :303-314